Drug makers in the United States have now reportedly applied for emergency FDA authorisation that would allow them to begin distributing their attempts at the COVD vaccinations. According to Vox, Pfizer and BioNTech have both made applications but it is unclear who will be applied to first. It remains unclear who will get the vaccine first due to the storage requirements of the vaccine and its requirements.
“Filing for Emergency Use Authorization in the US is a critical step in making our vaccine candidate available to the global population as quickly as possible,” said Ugur Sahin, CEO and cofounder of BioNTech, in a statement.
Leave a Reply